TY - JOUR
T1 - Hepatic manifestations of telomere biology disorders
AU - Patnaik, Mrinal M.
AU - Kamath, Patrick S.
AU - Simonetto, Douglas A.
N1 - Funding Information:
Current publication is supported in part by grants from the “The Gerstner Family Career Development Award” and the “Mayo Clinic Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA”. This publication was supported by CTSA Grant Number KL2 TR000136 from the National Center for Advancing Translational Science. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.
Publisher Copyright:
© 2018 European Association for the Study of the Liver
PY - 2018/9
Y1 - 2018/9
N2 - A 51-year-old Caucasian male was referred for evaluation of variceal bleeding. Laboratory tests were remarkable for mild thrombocytopenia and moderate alkaline phosphatase elevation. Synthetic liver function was well preserved. Abdominal computed tomography scan revealed moderate splenomegaly, gastric varices, and normal hepatic contour. A transjugular liver biopsy was performed revealing findings of nodular regenerative hyperplasia with no significant fibrosis or necroinflammatory activity. Hepatic venous pressure gradient was elevated at 31 mmHg, consistent with clinically significant portal hypertension. The clinical course was complicated by refractory gastric variceal bleeding requiring a surgical portosystemic shunt. Approximately seven years after the initial presentation, the patient developed progressive dyspnoea and a diagnosis of idiopathic pulmonary fibrosis was made. Contrast-enhanced echocardiogram was not suggestive of hepatopulmonary syndrome or portopulmonary hypertension. Given this new diagnosis a telomere biology disorder was suspected. A flow-fluorescence in situ hybridisation analysis for telomere length assessment revealed telomere lengths below the first percentile in both lymphocytes and granulocytes. Next generation sequencing analysis identified a heterozygous mutation involving the hTERT gene (Histidine983Threonine). The lung disease unfortunately progressed in the subsequent two years, leading to the patient's death nine years after his initial presentation with portal hypertension. During those nine years two brothers also developed idiopathic pulmonary fibrosis. The questions that arise from this case include: I. What are telomere biology disorders?II. What are the hepatic manifestations of telomere biology disorders?III. How are telomere biology disorders diagnosed?IV. Are there any potential therapeutic options for telomere biology disorders?
AB - A 51-year-old Caucasian male was referred for evaluation of variceal bleeding. Laboratory tests were remarkable for mild thrombocytopenia and moderate alkaline phosphatase elevation. Synthetic liver function was well preserved. Abdominal computed tomography scan revealed moderate splenomegaly, gastric varices, and normal hepatic contour. A transjugular liver biopsy was performed revealing findings of nodular regenerative hyperplasia with no significant fibrosis or necroinflammatory activity. Hepatic venous pressure gradient was elevated at 31 mmHg, consistent with clinically significant portal hypertension. The clinical course was complicated by refractory gastric variceal bleeding requiring a surgical portosystemic shunt. Approximately seven years after the initial presentation, the patient developed progressive dyspnoea and a diagnosis of idiopathic pulmonary fibrosis was made. Contrast-enhanced echocardiogram was not suggestive of hepatopulmonary syndrome or portopulmonary hypertension. Given this new diagnosis a telomere biology disorder was suspected. A flow-fluorescence in situ hybridisation analysis for telomere length assessment revealed telomere lengths below the first percentile in both lymphocytes and granulocytes. Next generation sequencing analysis identified a heterozygous mutation involving the hTERT gene (Histidine983Threonine). The lung disease unfortunately progressed in the subsequent two years, leading to the patient's death nine years after his initial presentation with portal hypertension. During those nine years two brothers also developed idiopathic pulmonary fibrosis. The questions that arise from this case include: I. What are telomere biology disorders?II. What are the hepatic manifestations of telomere biology disorders?III. How are telomere biology disorders diagnosed?IV. Are there any potential therapeutic options for telomere biology disorders?
KW - Cryptogenic cirrhosis
KW - Nodular regenerative hyperplasia
KW - Portal hypertension
KW - Telomere
KW - Telomere biology disorders
UR - http://www.scopus.com/inward/record.url?scp=85048531712&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048531712&partnerID=8YFLogxK
U2 - 10.1016/j.jhep.2018.05.006
DO - 10.1016/j.jhep.2018.05.006
M3 - Review article
C2 - 29758336
AN - SCOPUS:85048531712
SN - 0168-8278
VL - 69
SP - 736
EP - 743
JO - Journal of Hepatology
JF - Journal of Hepatology
IS - 3
ER -